First Trial of Potential ALS Gene Therapy VM202 Shows Treatment’s Safety – ALS News Today
ALS News Today |
First Trial of Potential ALS Gene Therapy VM202 Shows Treatment's Safety
ALS News Today The investigational gene therapy VM202, developed by VM BioPharma and intended for the treatment of amyotrophic lateral sclerosis (ALS), has been shown to be safe and well-tolerated in a small Phase 1/2 clinical trial, according to data published in … |
